Testosterone to Improve the Diagnosis and Treatment of Prostate Cancer
Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer– Brachytherapy
Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery
Clinical Update on PSMA Diagnostics and Therapies
Optilume® BPH Catheter System Data from the PINNACLE Trial in the September 2023 Journal of Urology
Updates in Chemoradiation for Bladder Urothelial Cancer
How to Differentiate the Causes of Lower Urinary Tract Symptoms
Treating BPH Comparing HoLEP, Rezum, and UroLift
Recurrent UTIs: Ask the Guideline
Treating BPH: Comparing Treatment Modalities
Sphincter-saving Technique in HoLEP Surgery
Treating BPH: Comparing HoLEP, Rezūm, UroLift, and Aquablation
Mortality Statistics After Prostatectomy and Radiation
Management of the Primary in Locally Advanced and Oligometastatic Disease
Evaluation and Management of Recurrent Prostate Cancer Following Radiation Therapy
The Manogram: Role of MRI in Prostate Cancer Screening
When to Use Hormone Therapy with Radiation Therapy
NCCN Guidelines for Treatment of Localized Prostate Cancer
Ask the Expert: What Are the Options in Treating Persistently Elevated PSA and Negative Biopsy?
New Prescribing Information on Survival Benefit for Nubeqa® (Darolutamide) Approved
Appropriate Use of PSMA PET in Clinical Practice
Active Surveillance in Favorable Intermediate-Risk Prostate Cancer
2018 Update on Peyronie's Disease - What's Around the Bend
Vitamin D and Prostate Cancer
New Treatment Options in LUTS
Painless Urology Using Nitrous Oxide Office-Based Procedures
Prostate Anatomy and Clinical Pathologic Considerations
ADT as Foundational Therapy: Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC
Guidelines and Practical Applications: Artificial Urinary Sphincter
In My Opinion: Biomarkers for the Diagnosis of Prostate Cancer
The HERO Study and the Approval of Relugolix
Transurethral Ultrasound Ablation (TULSA)
Need to Know: Experience with Lutetium (Pluvicto) for Prostate Cancer Theranostics
Announcing the Brian J. Moran Distinguished Lectureship
Point-Counterpoint: Active Surveillance for Intermediate-Risk Prostate Cancer - Pro
The Shifting Landscape of Minimally Invasive Urologic Surgery in the Era of Single Site Robotics
PSMA PET Gallium Scan Approved by FDA
Brachytherapy for Prostate Cancer
High Intensity Focused Ultrasound for Prostate Cancer
UW Urology Grand Rounds: "Workup of Small Renal Masses" - 1/17/2024
Controversies in Non-muscle Invasive Bladder Cancer (NMIBC): Guidelines and Beyond 2023
Recent Advances in Renal Cell Carcinoma
Saw Palmetto for BPH, Prostate Cancer, or Prostatitis?
Targeting AR in Castration Resistant Prostate Cancer
Identification of Localized Prostate Cancer
Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes
Next Generation DNA Sequencing for Genitourinary Implants
UW Urology Grand Rounds: Lasers in Endourology – 1/11/2023
Multimodal Approach to Advanced Prostate Cancer
Prostate Cancer: Expert Advice for Helping Your Loved One
An Introduction to the Urinary Microbiome: Part 1 - A Primer
Case Based Decision Making for Treatment of MIBC
UW Urology Grand Rounds: "Learning HoLEP" - 10/18/2023
Update on Brachytherapy for Prostate Cancer 2020
Point-Counterpoint: Active Surveillance for Intermediate-Risk Prostate Cancer - Con
Hereditary Prostate Cancer
DECIPHER: Predicting Prognosis and Assisting Treatment Decisions for Prostate Cancer
